162
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

ORCID Icon, , , &
Pages 673-683 | Published online: 01 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yajing You, Tao Yang, Shuhang Wei, Zongxin Liu, Chenxi Liu, Zijian Shen, Yinuo Yang, Yuemin Feng, Ping Yao & Qiang Zhu. (2023) Survival of Patients with Hepatitis B-Related Hepatocellular Carcinoma with Concomitant Metabolic Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 16, pages 2283-2293.
Read now
Qing-Xia Wang, Jiao Xue, Mei-Jie Shi, Yu-Bao Xie, Huan-Ming Xiao, Sheng Li, Ming Lin & Xiao-Ling Chi. (2022) Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study. Diabetes, Metabolic Syndrome and Obesity 15, pages 2311-2322.
Read now

Articles from other publishers (1)

Laurens A. van Kleef, Robert J. de Knegt & Willem Pieter Brouwer. (2023) Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality. Hepatology 77:3, pages 942-948.
Crossref